CD8A and cancer: In this study, we showed that an iPSC-based cancer vaccine induces protective immunity in a mouse model of PDAC, and that such immunity is associated with an increase in antitumor CD8+ effector and memory T cell responses, an induction in cancer cell-specific antibody responses, and a decrease in immunosuppressive CD4+ T regulatory cells (Tregs).